EP1603535A4 - Aromatase inhibitor diagnosis and therapy - Google Patents

Aromatase inhibitor diagnosis and therapy

Info

Publication number
EP1603535A4
EP1603535A4 EP04757537A EP04757537A EP1603535A4 EP 1603535 A4 EP1603535 A4 EP 1603535A4 EP 04757537 A EP04757537 A EP 04757537A EP 04757537 A EP04757537 A EP 04757537A EP 1603535 A4 EP1603535 A4 EP 1603535A4
Authority
EP
European Patent Office
Prior art keywords
diagnosis
therapy
aromatase inhibitor
aromatase
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04757537A
Other languages
German (de)
French (fr)
Other versions
EP1603535A2 (en
Inventor
Michel Gensini
Tony Huang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethicon Inc
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Publication of EP1603535A2 publication Critical patent/EP1603535A2/en
Publication of EP1603535A4 publication Critical patent/EP1603535A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A61K51/1234—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Optics & Photonics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP04757537A 2003-03-18 2004-03-17 Aromatase inhibitor diagnosis and therapy Withdrawn EP1603535A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45551003P 2003-03-18 2003-03-18
US455510P 2003-03-18
PCT/US2004/008082 WO2004082626A2 (en) 2003-03-18 2004-03-17 Aromatase inhibitor diagnosis and therapy

Publications (2)

Publication Number Publication Date
EP1603535A2 EP1603535A2 (en) 2005-12-14
EP1603535A4 true EP1603535A4 (en) 2008-10-15

Family

ID=33030013

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04757537A Withdrawn EP1603535A4 (en) 2003-03-18 2004-03-17 Aromatase inhibitor diagnosis and therapy

Country Status (2)

Country Link
EP (1) EP1603535A4 (en)
WO (1) WO2004082626A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2366654T3 (en) * 2005-02-17 2011-10-24 HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT CO., LTD. BIOPHOSPHONATES TO TREAT ENDOMETRIOSIS.
CA2768444A1 (en) 2009-07-17 2011-01-20 Rigshospitalet Loading technique for preparing radionuclide and ionophore containing liposomes in which the ionophore is 2-hydroxyquionoline (carbostyril) or structurally related 2-hydroxyquinolines
AU2011344865B2 (en) 2010-12-14 2017-03-09 Rigshospitalet Entrapment of radionuclides in nanoparticle compositions
RU2481587C1 (en) * 2012-02-21 2013-05-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт акушерства и гинекологии им. Д.О. Отта" Северо-Западного отделения Российской академии медицинских наук Method for aromatase activity test
CN102920658B (en) * 2012-11-02 2015-01-21 艾韦特(溧阳)医药科技有限公司 Liposome combined with GLP-1 (Glucagon-Like Peptide-1) analogue and polyethylene glycol and preparation method of liposome
US9993427B2 (en) 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture
US10556916B2 (en) 2014-04-01 2020-02-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000062813A2 (en) * 1999-04-20 2000-10-26 The University Of British Columbia Cationic peg-lipids and methods of use
WO2001020990A1 (en) * 1999-09-23 2001-03-29 Bioresponse L.L.C. Phytochemicals for treatment of mastalgia and endometriosis
WO2001093836A2 (en) * 2000-06-09 2001-12-13 Teni Boulikas Encapsulation of polynucleotides and drugs into targeted liposomes
US20020177574A1 (en) * 2001-04-20 2002-11-28 Taylor Hugh S. Endometrial gene therapy
WO2002096927A2 (en) * 2001-05-29 2002-12-05 Ribozyme Pharmaceuticals, Incorporated Ribozyme based treatment of female reproductive diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527528A (en) * 1989-10-20 1996-06-18 Sequus Pharmaceuticals, Inc. Solid-tumor treatment method
JP2700595B2 (en) * 1992-05-21 1998-01-21 呉羽化学工業株式会社 Anti-aromatase agent containing azole derivative
US6056973A (en) * 1996-10-11 2000-05-02 Sequus Pharmaceuticals, Inc. Therapeutic liposome composition and method of preparation
EP1169064B1 (en) * 1999-04-02 2004-03-03 Center For Molecular Medicine And Immunology Method of detecting endometriosis

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000062813A2 (en) * 1999-04-20 2000-10-26 The University Of British Columbia Cationic peg-lipids and methods of use
WO2001020990A1 (en) * 1999-09-23 2001-03-29 Bioresponse L.L.C. Phytochemicals for treatment of mastalgia and endometriosis
WO2001093836A2 (en) * 2000-06-09 2001-12-13 Teni Boulikas Encapsulation of polynucleotides and drugs into targeted liposomes
US20020177574A1 (en) * 2001-04-20 2002-11-28 Taylor Hugh S. Endometrial gene therapy
WO2002096927A2 (en) * 2001-05-29 2002-12-05 Ribozyme Pharmaceuticals, Incorporated Ribozyme based treatment of female reproductive diseases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TAKAYAMA KAZUTO ET AL: "Treatment of severe postmenopausal endometriosis with an aromatase inhibitor", FERTILITY AND STERILITY, ELSEVIER SCIENCE INC, NEW YORK, NY, US, vol. 69, no. 4, 1 April 1998 (1998-04-01), pages 709 - 713, XP002379276, ISSN: 0015-0282 *

Also Published As

Publication number Publication date
WO2004082626A3 (en) 2004-11-11
EP1603535A2 (en) 2005-12-14
WO2004082626A2 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
AU2003294355A8 (en) Ca125 gene and its use for diagnostic and therapeutic interventions
PL1603507T3 (en) Cellulite ultrasound treatment
EP1758605A4 (en) Prouroguanylin as therapeutic and diagnostic agents
IL164211A0 (en) Il-18 inhibitors and peripheral vascular diseases
EP1825005A4 (en) Mer diagnostic and therapeutic agents
EP1551990A4 (en) Diagnosis and treatment of chemoresistant tumors
EP1572741A4 (en) Therapeutic and diagnostic agents
EP1781685A4 (en) Therapeutic and diagnostic agents
GB0303663D0 (en) Assays and medical treatments
GB0207411D0 (en) Azole compounds and their therapeutic use
GB0207410D0 (en) Compounds and their therapeutic use
EP1603535A4 (en) Aromatase inhibitor diagnosis and therapy
GB0326578D0 (en) Cancer diagnosis and therapy
GB0428170D0 (en) Mono and Combination Therapy
EP1951914A4 (en) Diagnostic and therapeutic methods and agents
EP1778228A4 (en) Therapeutic compound and treatments
GB0512726D0 (en) Multiple sclerosis therapy and diagnosis
EP1701736A4 (en) Therapeutic agents and uses therefor
EP1483407A4 (en) Methods of therapy and diagnosis
GB0311815D0 (en) Skin treatments
EP1684795A4 (en) Methods and agents for the treatment of cancer
GB0207409D0 (en) Benzofuran-2H-3-one compounds and their therapeutic use
GB0311816D0 (en) Skin treatments
EP1567863A4 (en) Methods of therapy and diagnosis
AU2003235665A8 (en) Diagnostic and therapeutic uses of topors

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050817

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
RBV Designated contracting states (corrected)

Designated state(s): DE ES FR GB IT

A4 Supplementary search report drawn up and despatched

Effective date: 20080911

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 15/00 20060101ALI20080905BHEP

Ipc: A61K 51/12 20060101ALI20080905BHEP

Ipc: A61K 9/127 20060101AFI20051027BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090421